An overview of the spindle assembly checkpoint status in oral cancer

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Teixeira, José Henrique ^a   Silva, Patrícia Manuela ^a,b   Reis, Rita Margarida ^a   Moura, Inês Moranguinho ^a   Marques, Sandra ^a   Fonseca, Joana ^a   Monteiro, Luís Silva ^a   Bousbaa, Hassan ^a,c,d  

^a INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA EM CIÊNCIAS E TECNOLOGIAS DA SAÚDE   (Portugal)

^b UNIVERSITY OF ALGARVE   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; DNA REPAIR; DOWN REGULATION; GENE AMPLIFICATION; GENE MUTATION; GENE TRANSLOCATION; HUMAN; M PHASE CELL CYCLE CHECKPOINT; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SURVIVAL RATE; TUMOR CELL; TUMOR GROWTH; GENETICS; GENOMIC INSTABILITY; METABOLISM; MOUTH TUMOR; OOCYTE; PATHOLOGY;

CDC20 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 20;

ANEUPLOIDY; CDC20 PROTEINS; CELL CYCLE PROTEINS; GENOMIC INSTABILITY; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; MOUTH NEOPLASMS; OOCYTES;

EID: 84903641337     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/145289     Document Type: Review

References (75)

1. Forastiere A., Koch W., Trotti A., Sidransky D., Head and neck cancer. The New England Journal of Medicine 2001 345 26 1890 1900 2-s2.0-0035960866 (Pubitemid 33716564)
2. Warnakulasuriya S., Global epidemiology of oral and oropharyngeal cancer. Oral Oncology 2009 45 4-5 309 316 2-s2.0-67349186933 10.1016/j.oraloncology. 2008.06.002
3. Reshmi S. C., Gollin S. M., Chromosomal instability in oral cancer cells. Journal of Dental Research 2005 84 2 107 117 2-s2.0-15544386624 10.1177/154405910508400203 (Pubitemid 43822042)
4. Sato H., Uzawa N., Takahashi K.-I., Myo K., Ohyama Y., Amagasa T., Prognostic utility of chromosomal instability detected by fluorescence in situ hybridization in fine-needle aspirates from oral squamous cell carcinomas. BMC Cancer 2010 10, article 182 2-s2.0-77951852458 10.1186/1471-2407-10-182
5. Diaz-Rodríguez E., Sotillo R., Schvartzman J.-M., Benezra R., Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proceedings of the National Academy of Sciences of the United States of America 2008 105 43 16719 16724 2-s2.0-55949096605 10.1073/pnas.0803504105
6. Sotillo R., Hernando E., Díaz-Rodríguez E., Teruya-Feldstein J., Cordón-Cardo C., Lowe S. W., Benezra R., Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007 11 1 9 23 2-s2.0-33845986330 10.1016/j.ccr.2006.10.019 (Pubitemid 46054519)
7. Weaver B. A. A., Silk A. D., Montagna C., Verdier-Pinard P., Cleveland D. W., Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 2007 11 1 25 36 2-s2.0-33846065784 10.1016/j.ccr.2006.12.003 (Pubitemid 46070223)
8. Musacchio A., Salmon E. D., The spindle-assembly checkpoint in space and time. Nature Reviews Molecular Cell Biology 2007 8 5 379 393 2-s2.0-34247333444 10.1038/nrm2163 (Pubitemid 46643240)
9. Silva P., Barbosa J., Nascimento A. V., Faria J., Reis R., Bousbaa H., Monitoring the fidelity of mitotic chromosome segregation by the spindle assembly checkpoint. Cell Proliferation 2011 44 5 391 400 2-s2.0-80053152679 10.1111/j.1365-2184.2011.00767.x
10. Tanaka T., Tanaka M., Tanaka T., Oral carcinogenesis and oral cancer chemoprevention: a review. Pathology Research International 2011 2011 10 431246 10.4061/2011/431246
11. Tsantoulis P. K., Kastrinakis N. G., Tourvas A. D., Laskaris G., Gorgoulis V. G., Advances in the biology of oral cancer. Oral Oncology 2007 43 6 523 534 2-s2.0-34249844797 10.1016/j.oraloncology.2006.11.010 (Pubitemid 46860349)
12. Yan W., Wistuba I. I., Emmert-Buck M. R., Erickson H. S., Squamous cell carcinoma-similarities and differences among anatomical sites. American Journal of Cancer Research 2011 1 3 275 300
13. Rothenberg S. M., Ellisen L. W., The molecular pathogenesis of head and neck squamous cell carcinoma. Journal of Clinical Investigation 2012 122 6 1951 1957 2-s2.0-84861805678 10.1172/JCI59889
14. Llewellyn C. D., Johnson N. W., Warnakulasuriya K. A. A. S., Risk factors for squamous cell carcinoma of the oral cavity in young people-a comprehensive literature review. Oral Oncology 2001 37 5 401 418 2-s2.0-0035006330 10.1016/S1368-8375(00)00135-4 (Pubitemid 32480278)
15. Miller C. S., White D. K., Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 1996 82 1 57 68 2-s2.0-0030184789 (Pubitemid 126813002)
16. Sugerman P. B., Shillitoe E. J., The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Diseases 1997 3 3 130 147 2-s2.0-0030759188 (Pubitemid 27438812)
17. Monteiro L. S., Antunes L., Bento M. J., Warnakulasuriya S., Incidence rates and trends of lip, oral and oro-pharyngeal cancers in Portugal. Journal of Oral Pathology & Medicine 2013 42 4 345 351 2-s2.0-84875807517 10.1111/jop.12010
18. Neville B. W., Day T. A., Oral cancer and precancerous lesions. Ca: A Cancer Journal for Clinicians 2002 52 4 195 215 2-s2.0-0036347157
19. Mehrotra R., Gupta A., Singh M., Ibrahim R., Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Molecular Cancer 2006 5, article 11 2-s2.0-33646126700 10.1186/1476-4598-5-11
20. Patel V., Leethanakul C., Gutkind J. S., New approaches to the understanding of the molecular basis of oral cancer. Critical Reviews in Oral Biology and Medicine 2001 12 1 55 63 2-s2.0-0035033131 (Pubitemid 32374284)
21. Islam M. N., Kornberg L., Veenker E., Cohen D. M., Bhattacharyya I., Anatomic site based ploidy analysis of oral premalignant lesions. Head and Neck Pathology 2010 4 1 10 14 2-s2.0-77952888219 10.1007/s12105-009-0151-0
22. Scully C., Bedi R., Ethnicity and oral cancer. The Lancet Oncology 2000 1 1 37 42 2-s2.0-0034285720
23. Gleich L. L., Salamone F. N., Molecular genetics of head and neck cancer. Cancer Control 2002 9 5 369 378 2-s2.0-0036750327 (Pubitemid 35204459)
24. Humayun S., Prasad V. R., Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: an immunohistochemical study. National Journal of Maxillofacial Surgery 2011 2 1 38 46 10.4103/0975-5950.85852
25. Liggett W. H. Jr., Sidransky D., Role of the p16 tumor suppressor gene in cancer. Journal of Clinical Oncology 1998 16 3 1197 1206 2-s2.0-0344301900 (Pubitemid 28108758)
26. Williams H. K., Molecular pathogenesis of oral squamous carcinoma. Journal of Clinical Pathology: Molecular Pathology 2000 53 4 165 172 2-s2.0-0033866818 10.1136/mp.53.4.165 (Pubitemid 30603069)
27. Yarbrough W. G., Shores C., Witsell D. L., Weissler M. C., Fidler M. E., Gilmer T. M., ras mutations and expression in head and neck squamous cell carcinomas. Laryngoscope 1994 104 11, part 1 1337 1347 2-s2.0-0028046339 (Pubitemid 24346961)
28. Holland A. J., Cleveland D. W., Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nature Reviews Molecular Cell Biology 2009 10 7 478 487 2-s2.0-67649522162 10.1038/nrm2718
29. Foley E. A., Kapoor T. M., Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nature Reviews Molecular Cell Biology 2013 14 1 25 37 2-s2.0-84871530214 10.1038/nrm3494
30. Sudakin V., Chan G. K. T., Yen T. J., Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. The Journal of Cell Biology 2001 154 5 925 936 2-s2.0-0035802122 10.1083/jcb.200102093 (Pubitemid 34286173)
31. Rieder C. L., Cole R. W., Khodjakov A., Sluder G., The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores. The Journal of Cell Biology 1995 130 4 941 948 2-s2.0-0029160299 10.1083/jcb.130.4.941
32. de Antoni A., Pearson C. G., Cimini D., Canman J. C., Sala V., Nezi L., Mapelli M., Sironi L., Faretta M., Salmon E. D., Musacchio A., The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint. Current Biology 2005 15 3 214 225 2-s2.0-13444288299 10.1016/j.cub.2005.01.038 (Pubitemid 40205701)
33. Yu H., Structural activation of Mad2 in the mitotic spindle checkpoint: The two-state Mad2 model versus the Mad2 template model. The Journal of Cell Biology 2006 173 2 153 157 2-s2.0-33646092999 10.1083/jcb.200601172
34. Luo X., Yu H., Protein metamorphosis: the two-state behavior of Mad2. Structure 2008 16 11 1616 1625 2-s2.0-55249120526 10.1016/j.str.2008.10.002
35. Skinner J. J., Wood S., Shorter J., Englander S. W., Black B. E., The Mad2 partial unfolding model: regulating mitosis through Mad2 conformational switching. The Journal of Cell Biology 2008 183 5 761 768 2-s2.0-58149299775 10.1083/jcb.200808122
36. Han J., Holland A., Fachinetti D., Kulukian A., Cetin B., Cleveland D., Catalytic assembly of the mitotic checkpoint inhibitor BubR1-Cdc20 by a Mad2-induced functional switch in Cdc20. Molecular Cell 2013 51 1 92 104 2-s2.0-84879034627 10.1016/j.molcel.2013.05.019
37. Brady D. M., Hardwick K. G., Complex formation between Mad1p, Bub1p and Bub3p is crucial for spindle checkpoint function. Current Biology 2000 10 11 675 678 2-s2.0-0034214405 10.1016/S0960-9822(00)00515-7 (Pubitemid 30354705)
38. Johnson V. L., Scott M. I. F., Holt S. V., Hussein D., Taylor S. S., Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression. Journal of Cell Science 2004 117 part 8 1577 1589 2-s2.0-2342439525 10.1242/jcs.01006 (Pubitemid 38559832)
39. Tang Z., Shu H., Oncel D., Chen S., Yu H., Phosphorylation of Cdc20 by Bub1 provides a catalytic mechanism for APC/C inhibition by the spindle checkpoint. Molecular Cell 2004 16 3 387 397 2-s2.0-7744230752 10.1016/j.molcel.2004.09.031 (Pubitemid 39504793)
40. Kang J., Yang M., Li B., Qi W., Zhang C., Shokat K. M., Tomchick D. R., Machius M., Yu H., Structure and substrate recruitment of the human spindle checkpoint kinase Bub1. Molecular Cell 2008 32 3 394 405 2-s2.0-55049093739 10.1016/j.molcel.2008.09.017
41. Abrieu A., Magnaghi-Jaulin L., Kahana J. A., Peter M., Castro A., Vigneron S., Lorca T., Cleveland D. W., Labbé J.-C., Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint. Cell 2001 106 1 83 93 2-s2.0-0035854379 10.1016/S0092-8674(01)00410-X (Pubitemid 32709960)
42. Jelluma N., Dansen T. B., Sliedrecht T., Kwiatkowski N. P., Kops G. J. P. L., Release of Mps1 from kinetochores is crucial for timely anaphase onset. The Journal of Cell Biology 2010 191 2 281 290 2-s2.0-77958508464 10.1083/jcb.201003038
43. Liu S.-T., Chan G. K. T., Hittle J. C., Fujii G., Lees E., Yen T. J., Human MPS1 kinase is required for mitotic arrest induced by the loss of CENP-E from kinetochores. Molecular Biology of the Cell 2003 14 4 1638 1651 2-s2.0-0038709284 10.1091/mbc.02-05-0074 (Pubitemid 36547428)
44. Vigneron S., Prieto S., Bernis C., Labbé J.-C., Castro A., Lorca T., Kinetochore localization of spindle checkpoint proteins: who controls whom? Molecular Biology of the Cell 2004 15 10 4584 4596 2-s2.0-4444249610 10.1091/mbc.E04-01-0051 (Pubitemid 39299106)
45. Ruchaud S., Carmena M., Earnshaw W. C., The chromosomal passenger complex: one for all and all for one. Cell 2007 131 2 230 231 2-s2.0-35348842285 10.1016/j.cell.2007.10.002 (Pubitemid 47577519)
46. Tanaka T. U., Rachidi N., Janke C., Pereira G., Galova M., Schiebel E., Stark M. J. R., Nasmyth K., Evidence that the Ipl1-Sli15 (Aurora Kinase-INCENP) complex promotes chromosome bi-orientation by altering kinetochore-spindle pole connections. Cell 2002 108 3 317 329 2-s2.0-0036178929 10.1016/S0092-8674(02) 00633-5 (Pubitemid 34178397)
47. DeLuca K. F., Lens S. M. A., DeLuca J. G., Temporal changes in Hec1 phosphorylation control kinetochore-microtubule attachment stability during mitosis. Journal of Cell Science 2011 124 part 4 622 634 2-s2.0-79951833036 10.1242/jcs.072629
48. Ditchfield C., Johnson V. L., Tighe A., Ellston R., Haworth C., Johnson T., Mortlock A., Keen N., Taylor S. S., Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. The Journal of Cell Biology 2003 161 2 267 280 2-s2.0-0013057087 10.1083/jcb.200208091 (Pubitemid 36529846)
49. Howell B. J., McEwen B. F., Canman J. C., Hoffman D. B., Farrar E. M., Rieder C. L., Salmon E. D., Cytoplasmic dynein/dynactin drives kinetochore protein transport to the spindle poles and has a role in mitotic spindle checkpoint inactivation. The Journal of Cell Biology 2001 155 7 1159 1172 2-s2.0-0035945356 10.1083/jcb.200105093 (Pubitemid 34286267)
50. Kops G. J. P. L., Weaver B. A. A., Cleveland D. W., On the road to cancer: aneuploidy and the mitotic checkpoint. Nature Reviews Cancer 2005 5 10 773 785 2-s2.0-25844475838 10.1038/nrc1714 (Pubitemid 41400777)
51. Kops G. J. P. L., Foltz D. R., Cleveland D. W., Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proceedings of the National Academy of Sciences of the United States of America 2004 101 23 8699 8704 2-s2.0-2942567685 10.1073/pnas.0401142101 (Pubitemid 38745834)
52. Janssen A., Medema R. H., Mitosis as an anti-cancer target. Oncogene 2011 30 25 2799 2809 2-s2.0-79959684880 10.1038/onc.2011.30
53. Salmela A.-L., Kallio M. J., Mitosis as an anti-cancer drug target. Chromosoma 2013 122 5 431 449 2-s2.0-84878894137 10.1007/s00412-013-0419-8
54. Chan K.-S., Koh C.-G., Li H.-Y., Mitosis-targeted anti-cancer therapies: where they stand. Cell Death and Disease 2012 3 10, article e411 2-s2.0-84870527677 10.1038/cddis.2012.148
55. Brito D. A., Rieder C. L., Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Current Biology 2006 16 12 1194 1200 2-s2.0-33744996707 10.1016/j.cub.2006.04.043 (Pubitemid 43867292)
56. Gascoigne K. E., Taylor S. S., Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 2008 14 2 111 122 2-s2.0-48449098623 10.1016/j.ccr.2008.07.002
57. Gollin S. M., Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head & Neck 2001 23 3 238 253 (Pubitemid 32193221)
58. Mondal G., Sengupta S., Panda C. K., Gollin S. M., Saunders W. S., Roychoudhury S., Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis 2007 28 1 81 92 2-s2.0-33845657904 10.1093/carcin/bgl100 (Pubitemid 44942629)
59. Thirthagiri E., Robinson C. M., Huntley S., Davies M., Yap L. F., Prime S. S., Paterson I. C., Spindle assembly checkpoint and centrosome abnormalities in oral cancer. Cancer Letters 2007 258 2 276 285 2-s2.0-36048938976 10.1016/j.canlet.2007.09.008 (Pubitemid 350101025)
60. Tanaka K., Mohri Y., Ohi M., Yokoe T., Koike Y., Morimoto Y., Miki C., Tonouchi H., Kusunoki M., Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy. Clinical Oncology 2008 20 8 639 646 2-s2.0-51249102734 10.1016/j.clon.2008.06.010
61. Moura I. M., Delgado M. L., Silva P. M., Lopes C. A., do Amaral J. B., Monteiro L. S., Bousbaa H., High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 2014 43 3 225 231 10.1111/jop.12115
62. Hsieh P.-C., Chen Y.-K., Tsai K.-B., Shieh T.-Y., Chang Y.-Y., Chang J.-G., Wu H.-L., Lin S.-F., Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2010 109 2 257 267 2-s2.0-74149088596 10.1016/j.tripleo.2009.08.014
63. Lira R. C. P., Miranda F. A., Guimarães M. C. M., Simões R. T., Donadi E. A., Soares C. P., Soares E. G., BUBR1 expression in benign oral lesions and squamous cell carcinomas: correlation with human papillomavirus. Oncology Reports 2010 23 4 1027 1036 2-s2.0-77949426000 10.3892/or-00000729
64. Rizzardi C., Torelli L., Barresi E., Schneider M., Canzonieri V., Biasotto M., di Lenarda R., Melato M., BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival. Head & Neck 2011 33 5 727 733 2-s2.0-79954479155 10.1002/hed.21532
65. Hannisdal K., Burum-Auensen E., Schjølberg A., de Angelis P. M., Clausen O. P. F., Correlation between reduced expression of the spindle checkpoint protein BubR1 and bad prognosis in tonsillar carcinomas. Head & Neck 2010 32 10 1354 1362 2-s2.0-78649487453 10.1002/hed.21342
66. Pannone G., Hindi S. A. H., Santoro A., Sanguedolce F., Rubini C., Cincione R. I., de Maria S., Tortorella S., Rocchetti R., Cagiano S., Pedicillo C., Serpico R., lo Muzio L., Bufo P., Aurora B expression as a prognostic indicator and possibile therapeutic target in oral squamous cell carcinoma. International Journal of Immunopathology and Pharmacology 2011 24 1 79 88 2-s2.0-79957914407
67. Qi G., Ogawa I., Kudo Y., Miyauchi M., Siriwardena B. S. M. S., Shimamoto F., Tatsuka M., Takata T., Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer. Virchows Archiv 2007 450 3 297 302 2-s2.0-33847762885 10.1007/s00428-006-0360-9 (Pubitemid 46376560)
68. Chen J.-H., Yeh K.-T., Yang Y.-M., Chang J.-G., Lee H.-E., Hung S.-Y., High expressions of histone methylation- and phosphorylation-related proteins are associated with prognosis of oral squamous cell carcinoma in male population of Taiwan. Medical Oncology 2013 30 2, article 513 2-s2.0-84874935991 10.1007/s12032-013-0513-z
69. Wu W.-J., Hu K.-S., Wang D.-S., Zeng Z.-L., Zhang D.-S., Chen D.-L., Bai L., Xu R.-H., CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer. Journal of Translational Medicine 2013 11 1, article 142 2-s2.0-84878684149 10.1186/1479-5876-11-142
70. Yamamoto Y., Matsuyama H., Chochi Y., Okuda M., Kawauchi S., Inoue R., Furuya T., Oga A., Naito K., Sasaki K., Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Cancer Genetics and Cytogenetics 2007 174 1 42 47 2-s2.0-33847625012 10.1016/j.cancergencyto.2006.11.012 (Pubitemid 46365984)
71. Lin Z.-Z., Jeng Y.-M., Hu F.-C., Pan H.-W., Tsao H.-W., Lai P.-L., Lee P.-H., Cheng A.-L., Hsu H.-C., Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B overexpression in HCC. BMC Cancer 2010 10, article 461 2-s2.0-77956874718 10.1186/1471-2407-10-461
72. Schvartzman J.-M., Sotillo R., Benezra R., Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nature Reviews Cancer 2010 10 2 102 115 2-s2.0-75149140916 10.1038/nrc2781
73. Kollareddy M., Zheleva D., Dzubak P., Brahmkshatriya P. S., Lepsik M., Hajduch M., Aurora kinase inhibitors: progress towards the clinic. Investigational New Drugs 2012 30 6 2411 2432 2-s2.0-84873869465 10.1007/s10637-012-9798-6
74. Dennis M., Davies M., Oliver S., D'Souza R., Pike L., Stockman P., Phase i study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia. Cancer Chemotherapy and Pharmacology 2012 70 3 461 469 2-s2.0-84866434859 10.1007/s00280-012-1939-2
75. Wilkinson R. W., Odedra R., Heaton S. P., Wedge S. R., Keen N. J., Crafter C., Foster J. R., Brady M. C., Bigley A., Brown E., Byth K. F., Barrass N. C., Mundt K. E., Foote K. M., Heron N. M., Jung F. H., Mortlock A. A., Boyle F. T., Green S., AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Clinical Cancer Research 2007 13 12 3682 3688 2-s2.0-34250739960 10.1158/1078-0432.CCR-06-2979 (Pubitemid 46955132)